Minerva Neurosciences, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE3Minerva Neurosciences, Inc.NERVAug 20

   2 insider filings

   Joseph H. Reilly, new insider at NERV

   Show all 2

   • 3New insider at NERVAug 20
   • 3New insider at NERVAug 20

   Joseph H. Reilly, reporting

2. ROUTINESCHEDULE 13G/AMinerva Neurosciences, Inc.NERVAug 14

   Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)

   BALYASNY ASSET MANAGEMENT L.P., filed by

3. ROUTINESCHEDULE 13G/AMinerva Neurosciences, Inc.NERVAug 13

   Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)

   FARALLON CAPITAL MANAGEMENT, L.L.C., filed by

4. ROUTINE8-KMinerva Neurosciences, Inc.NERVAug 12

   Current report

5. NOTABLE10-QMinerva Neurosciences, Inc.NERVAug 7

   Quarterly report

6. ROUTINE8-KMinerva Neurosciences, Inc.NERVAug 7

   Current report

7. ROUTINE4Minerva Neurosciences, Inc.NERVAug 3

   Inderjit Kaul, insider filing for NERV

   Inderjit Kaul, reporting

8. ROUTINESCHEDULE 13G/AMinerva Neurosciences, Inc.NERVJul 8

   Ownership stake disclosure by FEDERATED HERMES, INC. (amended)

   FEDERATED HERMES, INC., filed by

9. ROUTINE4Minerva Neurosciences, Inc.NERVJun 5

   7 insider filings

   Fouzia Laghrissi-Thode, insider filing for NERV

   Show all 7

   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5
   • 4Insider filing for NERVJun 5

   Fouzia Laghrissi-Thode, reporting

10. ROUTINE8-KMinerva Neurosciences, Inc.NERVJun 4

    Current report

11. ROUTINE8-KMinerva Neurosciences, Inc.NERVMay 27

    Current report

12. ROUTINE424B5Minerva Neurosciences, Inc.NERVMay 27

    Securities offering

13. ROUTINESCHEDULE 13GMinerva Neurosciences, Inc.NERVMay 15

    Ownership stake disclosure by JANUS HENDERSON GROUP PLC

    JANUS HENDERSON GROUP PLC, filed by

14. ROUTINESCHEDULE 13G/AMinerva Neurosciences, Inc.NERVMay 15

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)

    BALYASNY ASSET MANAGEMENT L.P., filed by

15. NOTABLE10-QMinerva Neurosciences, Inc.NERVMay 5

    Quarterly report

16. ROUTINE8-KMinerva Neurosciences, Inc.NERVMay 5

    Current report

17. ROUTINEARSMinerva Neurosciences, Inc.NERVApr 23

    Annual report to shareholders

18. ROUTINEDEFA14AMinerva Neurosciences, Inc.NERVApr 23

    Additional proxy materials

19. ROUTINEDEF 14AMinerva Neurosciences, Inc.NERVApr 23

    Proxy statement

20. ROUTINE4Minerva Neurosciences, Inc.NERVApr 22

    2 insider filings

    James Joseph O'Connor, insider filing for NERV

    Show all 2

    • 4Insider filing for NERVApr 22
    • 3New insider at NERVApr 22

    James Joseph O'Connor, reporting

21. ROUTINEPRE 14AMinerva Neurosciences, Inc.NERVApr 10

    Preliminary proxy statement

22. ROUTINE8-KMinerva Neurosciences, Inc.NERVApr 6

    Current report

23. ROUTINE8-KMinerva Neurosciences, Inc.NERVApr 2

    Current report

24. ROUTINE4Minerva Neurosciences, Inc.NERVApr 1

    Inderjit Kaul, insider filing for NERV

    Inderjit Kaul, reporting

25. ROUTINE144Minerva Neurosciences, Inc.NERVMar 31

    3 Form 144 notices

    Hermes Insurance Series Federated, planned sale of NERV shares

    Show all 3

    • 144Planned insider sale of NERV sharesMar 31
    • 144Planned insider sale of NERV sharesMar 31
    • 144Planned insider sale of NERV sharesMar 31

    Hermes Insurance Series Federated, reporting

26. ROUTINEEFFECTMinerva Neurosciences, Inc.NERVMar 20

    Registration declared effective

27. ROUTINES-3Minerva Neurosciences, Inc.NERVMar 11

    Securities offering

28. NOTABLE10-KMinerva Neurosciences, Inc.NERVMar 11

    Annual report

29. ROUTINE8-KMinerva Neurosciences, Inc.NERVMar 11

    Current report

30. ROUTINE144Minerva Neurosciences, Inc.NERVMar 10

    3 Form 144 notices

    Hermes Insurance Series Federated, planned sale of NERV shares

    Show all 3

    • 144Planned insider sale of NERV sharesMar 10
    • 144Planned insider sale of NERV sharesMar 10
    • 144Planned insider sale of NERV sharesMar 10

    Hermes Insurance Series Federated, reporting

31. ROUTINESCHEDULE 13GMinerva Neurosciences, Inc.NERVFeb 20

    Ownership stake disclosure by Coastlands Capital LP

    Coastlands Capital LP, filed by

32. ROUTINESCHEDULE 13GMinerva Neurosciences, Inc.NERVFeb 17

    Ownership stake disclosure by Logos Global Management LP

    Logos Global Management LP, filed by

33. ROUTINESCHEDULE 13GMinerva Neurosciences, Inc.NERVFeb 17

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.

    BALYASNY ASSET MANAGEMENT L.P., filed by

34. ROUTINESCHEDULE 13GMinerva Neurosciences, Inc.NERVFeb 12

    Ownership stake disclosure by Adage Capital Management, L.P.

    Adage Capital Management, L.P., filed by

35. ROUTINESCHEDULE 13G/AMinerva Neurosciences, Inc.NERVFeb 5

    Ownership stake disclosure by Farallon Capital Partners, L.P. (amended)

    Farallon Capital Partners, L.P., filed by

36. ROUTINE8-KMinerva Neurosciences, Inc.NERVFeb 3

    Current report

37. ROUTINEEFFECTMinerva Neurosciences, Inc.NERVJan 7

    Registration declared effective

38. ROUTINE424B3Minerva Neurosciences, Inc.NERVJan 6

    Securities offering

Older filings on EDGAR